Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

The Cisco Systems announced a quarterly dividend

8/16/23 CSCO

QIWI reported for 6 months of 2023

8/16/23 QIWI

Globaltrans shareholders approved the redomiciliation from Cyprus to Abu Dhabi

8/16/23 GLTR

Mechel reported for 6 months of 2023 by RAS

8/16/23 MTLR

Rosbank reported for 6 months of 2023 by IFRS

8/16/23 ROSB

JD.com reported for 6 months of 2023

8/16/23 JD

Gazprom Neft will launch an oil refining complex at the Omsk Refinery

8/16/23 SIBN

Derivatives market participants demonstrated record activity

8/16/23 MOEX

Ural Kuznitsa reported for 6 months of 2023 by RAS

8/16/23 URKZ

Korshunovsky GOK reported for 6 months of 2023 by RAS

8/16/23 KOGK